This content is machine translated Psoriasis treatment with biologics What are the latest trends? Novel oral therapies are currently being researched – promising data from clinical trials is now available. In the field of approved, subcutaneously administered IL-23 and IL-17 antagonists, current real-world data...…
View Post 4 min This content is machine translated "Small Molecules" at AD Current analyses of the pioneer among the JAK-i The first representative of the Janus kinase (JAK) inhibitor class to be approved for atopic dermatitis was baricitinib. In an extensive study program, this selective and reversible inhibitor of JAK-1…
View Post 4 min This content is machine translated AID systems for type 1 diabetes New real-world data shows: AI makes the difference In hybrid closed-loop systems, algorithms control the automated insulin delivery (AID). Compared to conventional insulin administration, this not only has a favorable effect on HbA1c values, but also on patient-oriented…
View Post 3 min This content is machine translated Hereditary angioedema New Real-World Data on Long-Term Prophylaxis Hereditary angioedema (HAE) is a rare genetic disorder that causes recurrent swelling of the skin, mucous membranes, or various internal organs at irregular intervals. International guidelines recommend long-term prophylaxis with…
View Post 6 min This content is machine translated RCT, "real world data" or meta-analyses What counts in the treatment of multiple sclerosis? Randomized controlled trials remain the pivotal gold standard in the field of MS therapy studies. “Real-world observational data from large cohorts or registries can, however, provide valuable supplements for many…
View Post 6 min This content is machine translated Annual Swiss Psoriasis Day Thematic aspects of psoriasis in a new light At the Annual Swiss Psoriasis Day in Basel, the benefits of international and national psoriasis registries were discussed. Furthermore, the possibility of therapy optimization in severe and moderate plaque psoriasis…